Citation: M. Rufer et al., Combined therapy in anxiety disorders: Current data and recommendations for the clinical practice, VERHALTENST, 11(3), 2001, pp. 160-172
Citation: H. Peter et al., Combined treatment of agoraphobia and panic disorders with behavioral and drug therapy. Critical view on meta-analyses, VERHALTENST, 11(3), 2001, pp. 174-178
Citation: I. Hand et al., Combined behavioral and pharmacological treatment for obsessive-compulsivedisorders: Research findings and clinical practice, VERHALTENST, 11(3), 2001, pp. 206-215
Authors:
Moritz, S
Birkner, C
Kloss, M
Jacobsen, D
Fricke, S
Bothern, A
Hand, I
Citation: S. Moritz et al., Impact of comorbid depressive symptoms on neuropsychological performance in obsessive-compulsive disorder, J ABN PSYCH, 110(4), 2001, pp. 653-657
Authors:
Hand, I
Peter, H
Friedrich, B
Dahme, B
von Schinckel, J
Rickers, A
Citation: I. Hand et al., Psychotherapeutic outpatient units: The outpatient unit for behavior therapy at the University Hospital Hamburg-Eppendorf, VERHALTENST, 10(3), 2000, pp. 187-194
Citation: H. Peter et al., Serum cholesterol in patients with obsessive compulsive disorder during treatment with behavior therapy and SSRI or placebo, INT J PSY M, 30(1), 2000, pp. 27-39
Citation: H. Peter et al., Clinically relevant cholesterol elevation in anxiety disorders: A comparison with normal controls, INT J BEH M, 6(1), 1999, pp. 30-39
Citation: Pn. Goebel et al., Neuroticism, other personality variables, and serum lipid levels in patients with anxiety disorders and normal controls, INT J PSY M, 28(4), 1998, pp. 449-462